Reuters logo
8 天前
BRIEF-Bellicum Pharmaceuticals qtrly loss per share $0.74
2017年8月8日 / 晚上9点28分 / 8 天前

BRIEF-Bellicum Pharmaceuticals qtrly loss per share $0.74

1 分钟阅读

Aug 8 (Reuters) - Bellicum Pharmaceuticals Inc

* Bellicum pharmaceuticals reports second quarter 2017 financial results and provides corporate update

* Bellicum pharmaceuticals inc qtrly loss per share $0.74

* Bellicum pharmaceuticals inc says enrollment in pivotal eu bp-004 trial remains on track for completion by end of 2017

* Bellicum pharmaceuticals -expects to initiate observational trial in pediatric patients receiving transplants from matched unrelated donors without bpx-501 in q3 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below